Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
162.55 | -21.32% | -10.92% | 287,359.66 | 3.81% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
300.30 | -8.45% | 0.72% | 160,651.46 | 3.01% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.46 | 24.92% | 34.48% | 81,726.37 | 4.7% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
218.92 | -11.72% | 3.94% | 32,238.06 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
82.58 | 139.04% | 217.43% | 15,589.13 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
54.37 | 106.98% | 155.97% | 11,887.19 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
79.61 | 0% | 0% | 8,775.14 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
108.55 | 0% | 0% | 6,711.91 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
13.98 | 0% | 0% | 3,296.42 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
25.00 | 0% | 0% | 2,989.63 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
10.42 | 0% | 0% | 2,958.8 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
17.25 | 0% | 0% | 2,816.72 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
42.21 | 0% | 0% | 2,805.15 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
49.52 | -94.47% | -74.71% | 2,215.07 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
9.31 | 0% | 0% | 2,040.28 | 0% | 0% |
